Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Price cap of...

    Price cap of Orthopaedic Knee Implants led to boosted sales, says NPPA

    Farhat NasimWritten by Farhat Nasim Published On 2019-09-11T18:42:51+05:30  |  Updated On 16 Aug 2021 5:30 PM IST

    New Delhi: The apex drug price regulator, the National Pharmaceutical Pricing Authority (NPPA) has apprised about the positive impact of capping ceiling prices of Orthopaedic Knee Implants, as the sale of the product has increased by 30% over the past one year between July 2018 and July 2019.


    NPPA first slashed MRPs of knee implants by up to 69 per cent, using extraordinary powers granted under the country's drug pricing regulations. Accordingly, the cost of knee implants was reduced significantly, up to 69%.


    In 2018, the Government had extended the cap on prices for knee implants, ranging from Rs 54,000 to Rs 1.14 lakh for a year. Providing relief to patients going for knee implants, NPPA had extended the ceiling prices till 15th August 2019.


    Also Read: Government extends caps price of knee implants for one more year


    Apart from the extension, NPPA via a notification had apprised that the maximum retail price (MRP) of orthopaedic knee implants will be monitored to make sure that the cost does not increase beyond 10 per cent in a given year.


    Also Read: Cost of orthopaedic knee implants will not be allowed to rise beyond 10 per cent: NPPA


    In August, NPPA held a meeting, under the Chairmanship of Shubhra Singh and deliberated upon the matter in detail. The Committed observed;




    "There is more than 30% increase in the sale of knee implants during the period of July 18 to June 19 in comparison to that of the previous year. It may be inferred that fixation of ceiling prices of orthopaedic knee implants under Para 19 of the DPCO, 2013 has contributed to increased access to affordable healthcare to the general public."



    Though the price cap has come as a relief to patients, the industry association has been facing a negative impact of the initiative to price cap knee implants. The association has proposed to the Government to consider 20% increase in the ceiling price of orthopaedic knee implants for all categories due to currency depreciation, they also mentioned that no price increase (even WPI adjustment) was given in the year 2018. Apart from this, the stakeholders also demanded a separate ceiling price for knee implants components like Bone cement and components required for revision surgery.


    However, NPPA has decided to continue the prices mechanism as pegged and added that the ceiling price of orthopaedics knee implants will be reviewed after a period of one year.

    affordable healthcareconsumer savingDPCODrugs Prices Control Ordergovt of indiaHealthcareimplant devicesknee implantknee implant costknee implant mrpknee implant noticeNational Pharmaceutical Pricing AuthorityNPPAorthopaedic implantprice cap

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok